APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buclizine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Buclizine Market Outlook and Growth Opportunities 2026

19 December 2025199 pages

Choose your research edition.

Industry ResearchBuclizine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Buclizine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Buclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buclizine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Buclizine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Buclizine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Buclizine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Buclizine market include Sanofi, Johnson and Johnson, Pfizer, UCB, Stuart Pharmaceuticals, Sinphar, Peili Pharmaceutical, MK Pharma and Meider Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Buclizine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Buclizine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Buclizine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Buclizine market size, projected growth trends, production technologies, key applications, and end-use industries.

Buclizine Segment by Company

Sanofi

Johnson and Johnson

Pfizer

UCB

Stuart Pharmaceuticals

Sinphar

Peili Pharmaceutical

MK Pharma

Meider Pharma

Mankind Pharma

Laboratorios Rocnarf

HUA Shin Chemical Pharmaceutical

Al Pharm

Buclizine Segment by Type

Hospital

Drug Store

Buclizine Segment by Application

Antiallergic Agent

Histamine H₁-Receptor Antagonist

Buclizine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Buclizine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Buclizine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Buclizine significant trends, drivers, influence factors in global and regions.

6. To analyze Buclizine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buclizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buclizine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buclizine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Buclizine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Buclizine industry.

Chapter 3: Detailed analysis of Buclizine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Buclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Buclizine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Buclizine Industry Trends Table 2. Buclizine Industry Drivers Table 3. Buclizine Industry Opportunities and Challenges Table 4. Buclizine Industry Restraints Table 5. Global Buclizine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Buclizine Revenue Share by Company (2021-2026) Table 7. Global Buclizine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Buclizine Sales Volume Share by Company (2021-2026) Table 9. Global Buclizine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Buclizine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Buclizine Key Company Manufacturing Base & Headquarters Table 12. Global Buclizine Company, Product Type & Application Table 13. Global Buclizine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Buclizine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Hospital Table 18. Significant Companies of Drug Store Table 19. Global Buclizine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Buclizine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Buclizine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Buclizine Sales Volume Share by Type (2021-2026) Table 23. Global Buclizine Sales Volume Share by Type (2027-2032) Table 24. Global Buclizine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Buclizine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Buclizine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Buclizine Sales Value Share by Type (2021-2026) Table 28. Global Buclizine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Antiallergic Agent Table 30. Significant Companies of Histamine H₁-Receptor Antagonist Table 31. Global Buclizine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Buclizine Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Buclizine Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Buclizine Sales Volume Share by Application (2021-2026) Table 35. Global Buclizine Sales Volume Share by Application (2027-2032) Table 36. Global Buclizine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Buclizine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Buclizine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Buclizine Sales Value Share by Application (2021-2026) Table 40. Global Buclizine Sales Value Share by Application (2027-2032) Table 41. Global Buclizine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Buclizine Sales by Region (2021-2026) & (K Units) Table 43. Global Buclizine Sales Market Share by Region (2021-2026) Table 44. Global Buclizine Sales by Region (2027-2032) & (K Units) Table 45. Global Buclizine Sales Market Share by Region (2027-2032) Table 46. Global Buclizine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Buclizine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Buclizine Sales Value Share by Region (2021-2026) Table 49. Global Buclizine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Buclizine Sales Value Share by Region (2027-2032) Table 51. Global Buclizine Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Buclizine Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Buclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Buclizine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Buclizine Sales by Country (2021-2026) & (K Units) Table 56. Global Buclizine Sales Market Share by Country (2021-2026) Table 57. Global Buclizine Sales by Country (2027-2032) & (K Units) Table 58. Global Buclizine Sales Market Share by Country (2027-2032) Table 59. Global Buclizine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Buclizine Sales Value Market Share by Country (2021-2026) Table 61. Global Buclizine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Buclizine Sales Value Market Share by Country (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sanofi Buclizine Product Portfolio Table 67. Sanofi Recent Development Table 68. Johnson and Johnson Company Information Table 69. Johnson and Johnson Business Overview Table 70. Johnson and Johnson Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Johnson and Johnson Buclizine Product Portfolio Table 72. Johnson and Johnson Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Buclizine Product Portfolio Table 77. Pfizer Recent Development Table 78. UCB Company Information Table 79. UCB Business Overview Table 80. UCB Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. UCB Buclizine Product Portfolio Table 82. UCB Recent Development Table 83. Stuart Pharmaceuticals Company Information Table 84. Stuart Pharmaceuticals Business Overview Table 85. Stuart Pharmaceuticals Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Stuart Pharmaceuticals Buclizine Product Portfolio Table 87. Stuart Pharmaceuticals Recent Development Table 88. Sinphar Company Information Table 89. Sinphar Business Overview Table 90. Sinphar Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sinphar Buclizine Product Portfolio Table 92. Sinphar Recent Development Table 93. Peili Pharmaceutical Company Information Table 94. Peili Pharmaceutical Business Overview Table 95. Peili Pharmaceutical Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Peili Pharmaceutical Buclizine Product Portfolio Table 97. Peili Pharmaceutical Recent Development Table 98. MK Pharma Company Information Table 99. MK Pharma Business Overview Table 100. MK Pharma Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. MK Pharma Buclizine Product Portfolio Table 102. MK Pharma Recent Development Table 103. Meider Pharma Company Information Table 104. Meider Pharma Business Overview Table 105. Meider Pharma Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Meider Pharma Buclizine Product Portfolio Table 107. Meider Pharma Recent Development Table 108. Mankind Pharma Company Information Table 109. Mankind Pharma Business Overview Table 110. Mankind Pharma Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Mankind Pharma Buclizine Product Portfolio Table 112. Mankind Pharma Recent Development Table 113. Laboratorios Rocnarf Company Information Table 114. Laboratorios Rocnarf Business Overview Table 115. Laboratorios Rocnarf Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Laboratorios Rocnarf Buclizine Product Portfolio Table 117. Laboratorios Rocnarf Recent Development Table 118. HUA Shin Chemical Pharmaceutical Company Information Table 119. HUA Shin Chemical Pharmaceutical Business Overview Table 120. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio Table 122. HUA Shin Chemical Pharmaceutical Recent Development Table 123. Al Pharm Company Information Table 124. Al Pharm Business Overview Table 125. Al Pharm Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Al Pharm Buclizine Product Portfolio Table 127. Al Pharm Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Buclizine Distributors List Table 131. Buclizine Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Buclizine Product Image Figure 2. Global Buclizine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buclizine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Buclizine Sales (2021-2032) & (K Units) Figure 5. Global Buclizine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Buclizine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Hospital Image Figure 10. Drug Store Image Figure 11. Global Buclizine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Buclizine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Buclizine Sales Volume Share by Type (2021-2032) Figure 14. Global Buclizine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Buclizine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Buclizine Sales Value Share by Type (2021-2032) Figure 17. Antiallergic Agent Image Figure 18. Histamine H₁-Receptor Antagonist Image Figure 19. Global Buclizine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Buclizine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Buclizine Sales Volume Share by Application (2021-2032) Figure 22. Global Buclizine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Buclizine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Buclizine Sales Value Share by Application (2021-2032) Figure 25. Global Buclizine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Buclizine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Buclizine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Buclizine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Buclizine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Buclizine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Buclizine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Buclizine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Buclizine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Buclizine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Buclizine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Buclizine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Buclizine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Buclizine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Buclizine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Buclizine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Buclizine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Buclizine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Buclizine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Hospital
  • Drug Store
Applications
  • Antiallergic Agent
  • Histamine H₁-Receptor Antagonist
Companies covered
  • Sanofi
  • Johnson and Johnson
  • Pfizer
  • UCB
  • Stuart Pharmaceuticals
  • Sinphar
  • Peili Pharmaceutical
  • MK Pharma
  • Meider Pharma
  • Mankind Pharma
  • Laboratorios Rocnarf
  • HUA Shin Chemical Pharmaceutical
  • Al Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Buclizine Sales Value (2021-2032)
  4. 1.2.2 Global Buclizine Sales Volume (2021-2032)
  5. 1.2.3 Global Buclizine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Buclizine Market Dynamics
  1. 2.1 Buclizine Industry Trends
  2. 2.2 Buclizine Industry Drivers
  3. 2.3 Buclizine Industry Opportunities and Challenges
  4. 2.4 Buclizine Industry Restraints
3 Buclizine Market by Company
  1. 3.1 Global Buclizine Company Revenue Ranking in 2025
  2. 3.2 Global Buclizine Revenue by Company (2021-2026)
  3. 3.3 Global Buclizine Sales Volume by Company (2021-2026)
  4. 3.4 Global Buclizine Average Price by Company (2021-2026)
  5. 3.5 Global Buclizine Company Ranking (2024-2026)
  6. 3.6 Global Buclizine Company Manufacturing Base and Headquarters
  7. 3.7 Global Buclizine Company Product Type and Application
  8. 3.8 Global Buclizine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Buclizine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Buclizine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Buclizine Market by Type
  1. 4.1 Buclizine Type Introduction
  2. 4.1.1 Hospital
  3. 4.1.2 Drug Store
  4. 4.2 Global Buclizine Sales Volume by Type
  5. 4.2.1 Global Buclizine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Buclizine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Buclizine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Buclizine Sales Value by Type
  9. 4.3.1 Global Buclizine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Buclizine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Buclizine Sales Value Share by Type (2021-2032)
5 Buclizine Market by Application
  1. 5.1 Buclizine Application Introduction
  2. 5.1.1 Antiallergic Agent
  3. 5.1.2 Histamine H₁-Receptor Antagonist
  4. 5.2 Global Buclizine Sales Volume by Application
  5. 5.2.1 Global Buclizine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Buclizine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Buclizine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Buclizine Sales Value by Application
  9. 5.3.1 Global Buclizine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Buclizine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Buclizine Sales Value Share by Application (2021-2032)
6 Buclizine Regional Sales and Value Analysis
  1. 6.1 Global Buclizine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Buclizine Sales by Region (2021-2032)
  3. 6.2.1 Global Buclizine Sales by Region: 2021-2026
  4. 6.2.2 Global Buclizine Sales by Region (2027-2032)
  5. 6.3 Global Buclizine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Buclizine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Buclizine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Buclizine Sales Value by Region (2027-2032)
  9. 6.5 Global Buclizine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Buclizine Sales Value (2021-2032)
  12. 6.6.2 North America Buclizine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Buclizine Sales Value (2021-2032)
  15. 6.7.2 Europe Buclizine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Buclizine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Buclizine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Buclizine Sales Value (2021-2032)
  21. 6.9.2 South America Buclizine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Buclizine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Buclizine Sales Value Share by Country, 2025 VS 2032
7 Buclizine Country-level Sales and Value Analysis
  1. 7.1 Global Buclizine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Buclizine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Buclizine Sales by Country (2021-2032)
  4. 7.3.1 Global Buclizine Sales by Country (2021-2026)
  5. 7.3.2 Global Buclizine Sales by Country (2027-2032)
  6. 7.4 Global Buclizine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Buclizine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Buclizine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Buclizine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Buclizine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Buclizine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Buclizine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Buclizine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Buclizine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Buclizine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Buclizine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Buclizine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Buclizine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Buclizine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Buclizine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Buclizine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Buclizine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Buclizine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Buclizine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Buclizine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Buclizine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Buclizine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Buclizine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Buclizine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Buclizine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Buclizine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Buclizine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Buclizine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Buclizine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Buclizine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Buclizine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Buclizine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Buclizine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Buclizine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Buclizine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Buclizine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Buclizine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Buclizine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Buclizine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Buclizine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Buclizine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Buclizine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Buclizine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Buclizine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Buclizine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Buclizine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Buclizine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Buclizine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Buclizine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Buclizine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Buclizine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Buclizine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Buclizine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Buclizine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Buclizine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Buclizine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Buclizine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Buclizine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Buclizine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Buclizine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Buclizine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Buclizine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Buclizine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Buclizine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Buclizine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Buclizine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Buclizine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Buclizine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Buclizine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Buclizine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Buclizine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Buclizine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Buclizine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Buclizine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Buclizine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Buclizine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Buclizine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Buclizine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Buclizine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Buclizine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Buclizine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Buclizine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Buclizine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Buclizine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Buclizine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Buclizine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Buclizine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Buclizine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Buclizine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson and Johnson
  8. 8.2.1 Johnson and Johnson Company Information
  9. 8.2.2 Johnson and Johnson Business Overview
  10. 8.2.3 Johnson and Johnson Buclizine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson and Johnson Buclizine Product Portfolio
  12. 8.2.5 Johnson and Johnson Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Buclizine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Buclizine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 UCB
  20. 8.4.1 UCB Company Information
  21. 8.4.2 UCB Business Overview
  22. 8.4.3 UCB Buclizine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 UCB Buclizine Product Portfolio
  24. 8.4.5 UCB Recent Developments
  25. 8.5 Stuart Pharmaceuticals
  26. 8.5.1 Stuart Pharmaceuticals Company Information
  27. 8.5.2 Stuart Pharmaceuticals Business Overview
  28. 8.5.3 Stuart Pharmaceuticals Buclizine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Stuart Pharmaceuticals Buclizine Product Portfolio
  30. 8.5.5 Stuart Pharmaceuticals Recent Developments
  31. 8.6 Sinphar
  32. 8.6.1 Sinphar Company Information
  33. 8.6.2 Sinphar Business Overview
  34. 8.6.3 Sinphar Buclizine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sinphar Buclizine Product Portfolio
  36. 8.6.5 Sinphar Recent Developments
  37. 8.7 Peili Pharmaceutical
  38. 8.7.1 Peili Pharmaceutical Company Information
  39. 8.7.2 Peili Pharmaceutical Business Overview
  40. 8.7.3 Peili Pharmaceutical Buclizine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Peili Pharmaceutical Buclizine Product Portfolio
  42. 8.7.5 Peili Pharmaceutical Recent Developments
  43. 8.8 MK Pharma
  44. 8.8.1 MK Pharma Company Information
  45. 8.8.2 MK Pharma Business Overview
  46. 8.8.3 MK Pharma Buclizine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MK Pharma Buclizine Product Portfolio
  48. 8.8.5 MK Pharma Recent Developments
  49. 8.9 Meider Pharma
  50. 8.9.1 Meider Pharma Company Information
  51. 8.9.2 Meider Pharma Business Overview
  52. 8.9.3 Meider Pharma Buclizine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Meider Pharma Buclizine Product Portfolio
  54. 8.9.5 Meider Pharma Recent Developments
  55. 8.10 Mankind Pharma
  56. 8.10.1 Mankind Pharma Company Information
  57. 8.10.2 Mankind Pharma Business Overview
  58. 8.10.3 Mankind Pharma Buclizine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mankind Pharma Buclizine Product Portfolio
  60. 8.10.5 Mankind Pharma Recent Developments
  61. 8.11 Laboratorios Rocnarf
  62. 8.11.1 Laboratorios Rocnarf Company Information
  63. 8.11.2 Laboratorios Rocnarf Business Overview
  64. 8.11.3 Laboratorios Rocnarf Buclizine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Laboratorios Rocnarf Buclizine Product Portfolio
  66. 8.11.5 Laboratorios Rocnarf Recent Developments
  67. 8.12 HUA Shin Chemical Pharmaceutical
  68. 8.12.1 HUA Shin Chemical Pharmaceutical Company Information
  69. 8.12.2 HUA Shin Chemical Pharmaceutical Business Overview
  70. 8.12.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio
  72. 8.12.5 HUA Shin Chemical Pharmaceutical Recent Developments
  73. 8.13 Al Pharm
  74. 8.13.1 Al Pharm Company Information
  75. 8.13.2 Al Pharm Business Overview
  76. 8.13.3 Al Pharm Buclizine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Al Pharm Buclizine Product Portfolio
  78. 8.13.5 Al Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Buclizine Value Chain Analysis
  2. 9.1.1 Buclizine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Buclizine Sales Mode & Process
  6. 9.2 Buclizine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Buclizine Distributors
  9. 9.2.3 Buclizine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst